The all-type nicking enzyme (ATE) from human HeLa cells or calf thymus
can nick DNA at the first phosphodiester bond 5' to all 8 possible mi
smatched bases. The strand disparity of this nicking is influenced by
the neighboring nucleotide sequences. After nicking, the ATE covalentl
y binds to the 3' end of the DNA product to form a cleavable complex,
whose formation is insensitive to camptothecin, a specific inhibitor o
f eukaryotic topoisomerase I (Topo-I). During the purification of ATE
from calf thymus, a Mg2+-independent relaxation activity, characterist
ic of eukaryotic Topo-I, copurifies with the mismatch-nicking activity
. The ATE from calf thymus may be a breakdown product of Topo-I. N-ter
minal amino acid analysis indicates that one of the polypeptides with
ATE activity contains the C-terminal portion of Topo-I. Moreover, acti
ve human Topo-I, expressed as a fusion protein in Escherichia coli, is
also capable of nicking all 8 base mispairs in the absence of Mg2+. T
his mismatch-specific nicking activity may be a novel property of the
mammalian Topo-I.